Skip to main content
SpringerLink
Log in

Cardiotoxic effects of the antiarrhythmic rhythmidazol and their correction by suphan, befol, and their combinations

  • Pharmacology and Toxicology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

The antiarrhythmic rhythmidazol produces a cardiotoxic effect that can be corrected by suphan, befol, and their combinations, as evidenced by normalization of ultrastructural organization of cardiomyocytes and myocardial oxygen consumption by these drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. V. V. Gatsura,Pharmacological Correction of Energy Exchange in the Ischemic Myocardium [in Russian], Moscow (1993).

  2. A. I. Grinevich, I. S. Chekman, P. A. Galenko-Yaroshevskii,et al., Dopov. Akad. Nauk Ukraine, No. 5, 169–173 (1994).

    Google Scholar 

  3. M. S. Kushakovskii,Cardiac Arrhythmias [in Russian], St. Petersburg (1992).

  4. V. B. Prozorovskii and M. P. Prozorovskaya,Farmakol. Toksikol.,43, No. 6, 733–735 (1980).

    PubMed  CAS  Google Scholar 

  5. V. V. Skibitskii, P. A. Galenko-Yaroshevskii, S. G. Kanorskii,et al., Vestn. Aritmol., No. 4, 227 (1995).

    Google Scholar 

  6. B. S. Weakley,Essentials of Electron Microscopy in Biology [Russian translation], Moscow (1975).

  7. A. I. Khankoeva, “A search for methods of moderation of cardiotoxic effects of antiarrhythmic drugs on the ischemic myocardium”, Author's Synopsis of PhD Dissertation [in Russian], Rostov-on-Don (1995).

  8. L. E. Kholodov and V. P. Yakovlev,Clinical Pharmacology [in Russian], Moscow (1985).

  9. V. A. Shakhlamov,Capillaries [in Russian], Moscow (1971).

  10. S. Loewe,Ergebh. Physiol.,27, 47 (1928).

    Google Scholar 

  11. S. Loewe,Pharmacol. Rev.,3, 237–242 (1957).

    Google Scholar 

  12. E. M. Vaughan-Williams,J. Clin. Pharmacol.,24, No. 1, 129–147 (1984).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Department of Hospital Therapy and Clinical Pharmacology, Kuban Medical Academy, Krasnodar

    P. A. Galenko-Yaroshevskii, V. V. Skibitskii, V. B. Boldin, M. M. Seredenko, A. I. Khankoeva & A. V. Uvarov

  2. Department of Hypoxia Research, A. A. Bogomolets Physiology Institute, Kiev

    P. A. Galenko-Yaroshevskii, V. V. Skibitskii, V. B. Boldin, M. M. Seredenko, A. I. Khankoeva & A. V. Uvarov

Authors
  1. P. A. Galenko-Yaroshevskii
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. V. Skibitskii
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. B. Boldin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. M. Seredenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. I. Khankoeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. V. Uvarov
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 124, No. 12, pp. 640–644, December, 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galenko-Yaroshevskii, P.A., Skibitskii, V.V., Boldin, V.B. et al. Cardiotoxic effects of the antiarrhythmic rhythmidazol and their correction by suphan, befol, and their combinations. Bull Exp Biol Med 124, 1189–1193 (1997). https://doi.org/10.1007/BF02445116

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02445116

Key Words

Search

Navigation